Company: INVUP
Filing Date: 2025-08-13
Form Type: 10-Q
Source: 0001493152-25-011912
Chunk: 54

Company: Investview, Inc.
Filing Date: 2025-08-13
Form: 10-Q
Item: Part I, Item 1
Chunk 54
---
     -  
     2,898,247  
     2,898,247 
  
    Depreciation 
     645  
     2,300,026  
     2,300,671 
  
    Gain on disposal of assets 
     -  
     180,223  
     180,233 
  
    General and administrative [1] 
     651,590  
     179,319  
     830,909 

    Segment income (loss) from operations 
    $7,344,542  
    $(2,456,910) 
    $4,887,632 

    [1]
    General
    and administrative costs consist mainly of professional fees, contracting services, insurance, information technology and software,
    and other payment processing fees.

    30

INVESTVIEW, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

AS OF JUNE 30, 2025

(Unaudited)

The
following table illustrates the reconciliation of segment operating income to net income before taxes for the six months ended June 30,
2025, and 2024.

    June 30,  2025  
    June 30,  2024 
  
    Segment income from operations 
    $2,160,473  
    $4,887,632 

    Reconciling items 

    Other profit (loss) [1] 
     (2,688,563) 
     (2,564,149)
  
    Bank interest 
     100,535  
     28,875 
  
    Event ticket sales 
     52,673  
     350,635 
  
    Leasing income 
     126,489  
     300,248 
  
    All other, net 
     (182) 
     (31,312)

    Net income (loss) before income taxes 
    $(248,575) 
    $2,971,929 

    [1]
    Other
    profit (loss) is attributable to corporate and nonoperating segment expenses, and is therefore not included in the total for segment
    gross profit (loss).

NOTE
13 – ACQUISITION

On
October 11, 2024, Renu Laboratories LLC (a wholly owned subsidiary of myLife Wellness Company which is a wholly owned